Lv4
560 积分 2022-04-15 加入
NCF2 drives tumor progression and metastasis through NR2F2/LATS2/YAP1 axis in esophageal squamous cell carcinoma
6天前
已完结
Exploiting Metabolic Vulnerabilities in Cancer: From Mechanisms to Therapeutic Opportunities
1个月前
已完结
MYO1F in neutrophils is required for the response to immune checkpoint blockade therapy
1个月前
已完结
Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer
1个月前
已完结
CHI3L3+ immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastases
1个月前
已完结
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
1个月前
已完结
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
1个月前
已完结
Tumor-associated neutrophils: A complex role in cancer
2个月前
已完结
Subtypes of tumor-associated neutrophils and their roles in cancer immunotherapy
2个月前
已完结
Biomarkers for immunotherapy of hepatocellular carcinoma
2个月前
已完结
皖公网安备34019202002308
